The Latest Breaking News from ABT

CUPRA Racing will make its first appearance in Formula E in the new 2022-23 season and will do so hand in hand with ABT. Why is it entering the category and what is the goal?

CUPRA has teamed up with ABT to compete in Formula E from 2023, marking the German manufacturer's return to the all-electric championship.

The 2022 DTM was a closely-fought affair that kept observers guessing until the final throes at Hockenheim, with the leading proponents from three different brands in contention. Here are the drivers who impressed the most

Healthcare industry tends to perform relatively well despite macroeconomic headwinds, thanks to near-inelastic demand for their products and services. So, we believe quality medical stocks UnitedHealth Group (UNH) and Abbott (ABT) might be ideal Buys for the long term. Keep reading….

The Fed’s continued hawkish monetary policy stance has raised fears of an impending recession. Despite the market pressure, the U.S. GDP saw a positive turnaround in the third quarter of 2022, indicating a resilient economy. Amid this scenario, we think investors should buy fundamentally sound stocks Abbott Laboratories (ABT), Verizon…

With an albeit decelerating yet solid employment report for October playing into the rationale for slower yet surer hikes by the Fed, the economy seems to be on the brink of a recession. Amid an uncertain economic backdrop, It could be wise to invest in fundamentally strong stocks, Abbott Laboratories…

With inflation hovering around the multi-decade high level, further aggressive interest rate hikes seem apparent. Given the weak market outlook, investors could cushion their portfolios by investing in fundamentally sound stocks PepsiCo (PEP), Cisco Systems (CSCO), Abbott Laboratories (ABT), Albertsons Companies (ACI), and Hillenbrand (HI), which have a history of…

Abt Sportsline is keeping its options open regarding its choice of manufacturer for the 2023 DTM season, but is confident of extending its long-standing relationship with Audi.

Despite the uncertain macro environment, Abbott (ABT) increased its adjusted EPS guidance for 2022. Wall Street analysts expect it to rally more than 20% in the near term. However, the stock is down 30% year-to-date. So, let's find out if it is the right time to invest in ABT….

Abt chief Thomas Biermaier feels his squad and Mahindra are operating as a four-car team as they gear up to compete in Formula E’s Gen3 era together in 2023.

Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.